NDC 43063-900 – LAMIVUDINE and ZIDOVUDINE

Lamivudine 150 mg/1; Zidovudine 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC43063-900

Product details

Brand name
LAMIVUDINE and ZIDOVUDINE
Generic name
LAMIVUDINE and ZIDOVUDINE
Labeler
PD-Rx Pharmaceuticals, Inc.
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA079124
Marketed since
September 18, 2015
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for LAMIVUDINE and ZIDOVUDINE →

Package NDC codes (1)

Package NDCDescriptionSince
43063-900-066 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-900-06)Oct 11, 2018

Other LAMIVUDINE and ZIDOVUDINE products